The present study strongly argues in favor of the second hypothesis: firstly MiniSOX9 is an inhibitor of SOX9 transcriptional activity, but is not able to prevent the SOX9 induced inhibition of both the Wnt/ß-catenin signaling pathway and the CRC cell proliferation (Figure 7). Here, SOX9 is linked to colorectal carcinoma.